X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
USA (Orange Book)
Europe
0
Canada
0
Australia
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
0
100
PharmaCompass offers a list of Ozanimod API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ozanimod manufacturer or Ozanimod supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ozanimod manufacturer or Ozanimod supplier.
PharmaCompass also assists you with knowing the Ozanimod API Price utilized in the formulation of products. Ozanimod API Price is not always fixed or binding as the Ozanimod Price is obtained through a variety of data sources. The Ozanimod Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ozanimod manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ozanimod, including repackagers and relabelers. The FDA regulates Ozanimod manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ozanimod API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ozanimod manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ozanimod supplier is an individual or a company that provides Ozanimod active pharmaceutical ingredient (API) or Ozanimod finished formulations upon request. The Ozanimod suppliers may include Ozanimod API manufacturers, exporters, distributors and traders.
click here to find a list of Ozanimod suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ozanimod DMF (Drug Master File) is a document detailing the whole manufacturing process of Ozanimod active pharmaceutical ingredient (API) in detail. Different forms of Ozanimod DMFs exist exist since differing nations have different regulations, such as Ozanimod USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ozanimod DMF submitted to regulatory agencies in the US is known as a USDMF. Ozanimod USDMF includes data on Ozanimod's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ozanimod USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ozanimod suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ozanimod Drug Master File in Korea (Ozanimod KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ozanimod. The MFDS reviews the Ozanimod KDMF as part of the drug registration process and uses the information provided in the Ozanimod KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ozanimod KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ozanimod API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ozanimod suppliers with KDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ozanimod as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ozanimod API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ozanimod as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ozanimod and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ozanimod NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ozanimod suppliers with NDC on PharmaCompass.
Ozanimod Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ozanimod GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ozanimod GMP manufacturer or Ozanimod GMP API supplier for your needs.
A Ozanimod CoA (Certificate of Analysis) is a formal document that attests to Ozanimod's compliance with Ozanimod specifications and serves as a tool for batch-level quality control.
Ozanimod CoA mostly includes findings from lab analyses of a specific batch. For each Ozanimod CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ozanimod may be tested according to a variety of international standards, such as European Pharmacopoeia (Ozanimod EP), Ozanimod JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ozanimod USP).
Market Place
